Publications
-
Lung shunting and radiation pneumonitis after holmium-166 TARE: a case study
Meike W M van Wijk, Marcel J R Janssen, Mark J Arntz, Bram H J Geurts, Laura A Michon, Eric T T L Tjwa, Joey Roosen, J Frank W Nijsen Purpose: The assessment of the lung shunting fraction (LSF) in yttrium-90 (90Y) or holmium-166 (166Ho) transarterial...
-
Development and validation of an innovative administration system to facilitate controlled holmium-166 microsphere administration during TARE
M.W.M. van Wijk, G. van Wolfswinkel, M.J. Arntz, M.J.R. Janssen, J. Roosen, J.F.W. Nijsen Background To develop and validate a novel administration device for holmium-166 transarterial radioembolisation (TARE) with the purpose of facilitating...
-
Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery
J. Roosen, L.E.L. Westlund Gotby, M.J. Arntz, J.J. Fütterer, M.J.R. Janssen, M.W. Konijnenberg, M.W.M. van Wijk, C.G. Overduin, J.F.W. Nijsen Purpose Transarterial radioembolization (TARE) is a treatment for liver tumours based on injection of...
-
Mark Arntz
Interventional radiologist